FDA [Food and Drug Administration] commissioner Scott Gottlieb yesterday called on brand name drug companies to end the shenanigans that restrict generic drug competition, specifically pointing to the tactic of slow-playing shared Risk Evaluation and Mitigation Strategies (REMS) terms intended to prevent generic manufacturers from purchasing drug products needed to run bioequivalence or bioavailability studies that FDA approval requires.

[Ignatz, under the rain:] It's a good thing I had this tarp handy. … / [Officer Pupp:] Gimme that canvas, it's much more important that I keep dry.

If the governor of Kentucky is now making colonels by the wholesale, he is doing it “for a reason.” It is a mere unfortunate incident, for him, that he can not make colonelesses and majoresses. The grip of the appointive power on the women is even stronger than on the men.

I taught myself.